Join
Live feed
·
INSIDERFilingvia Quantisnow
Edgewise Therapeutics Inc. logo

President and CEO Koch Kevin converted options into 17,968 shares and sold $106,764 worth of shares (7,972 units at $13.39), increasing direct ownership by 48% to 30,615 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EWTX· Edgewise Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EWTX (Edgewise Therapeutics Inc.) and more on Quantisnow.